Fate Therapeutics logo
Fate Therapeutics FATE
$ 3.57 2.0%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

Fate Therapeutics Long Term Debt 2011-2024 | FATE

Annual Long Term Debt Fate Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
97.4 M 104 M 109 M - - 12.4 M 14.8 M 2.5 M 10.7 M 18.1 M - 1.73 M 3.59 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
109 M 1.73 M 37.4 M

Quarterly Long Term Debt Fate Therapeutics

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
93.9 M 97.4 M 99 M 101 M 102 M 104 M 105 M - 108 M 109 M 104 M 105 M 107 M 93.9 M 93.9 M 93.9 M 93.9 M 25.2 M 25.2 M 9.47 M 11 M 12.4 M 12.4 M 12.4 M 12.4 M 14.8 M 14.8 M 14.8 M 14.8 M 2.5 M 2.5 M 2.5 M 2.5 M 10.7 M 10.7 M 10.7 M 10.7 M 18.1 M 18.1 M 18.1 M 18.1 M 1.75 M 250 K - - 1.73 M 1.73 M - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
109 M 250 K 43.7 M